Enzon Pharmaceuticals Financials
ENZNDelisted Stock | USD 0.20 0.01 5.26% |
With this module, you can analyze Enzon financials for your investing period. You should be able to track the changes in Enzon Pharmaceuticals individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Enzon |
Understanding current and past Enzon Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Enzon Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Enzon Pharmaceuticals' assets may result in an increase in income on the income statement.
The data published in Enzon Pharmaceuticals' official financial statements typically reflect Enzon Pharmaceuticals' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Enzon Pharmaceuticals' quantitative information. For example, before you start analyzing numbers published by Enzon accountants, it's essential to understand Enzon Pharmaceuticals' liquidity, profitability, and earnings quality within the context of the Biotechnology space in which it operates.
Enzon Pharmaceuticals Stock Summary
Enzon Pharmaceuticals competes with Pmv Pharmaceuticals, NewAmsterdam Pharma, Tempest Therapeutics, IO Biotech, and Cyclacel Pharmaceuticals. Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company was founded in 1981 and is headquartered in Cranford, New Jersey. Enzon Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.Specialization | Healthcare, Biotechnology |
Instrument | USA OTC Stock View All |
Exchange | OTCQX Exchange |
ISIN | US2939041081 |
CUSIP | 293904108 |
Location | New Jersey; U.S.A |
Business Address | 20 Commerce Drive, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.enzon.com |
Phone | 732 980 4500 |
Currency | USD - US Dollar |
Enzon Pharmaceuticals Key Financial Ratios
Enzon Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Enzon Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Enzon Pharmaceuticals over time and compare it to other companies across industries.Return On Equity | -0.016 | ||||
Return On Asset | -0.0138 | ||||
Target Price | 14.0 | ||||
Beta | 0.17 | ||||
Z Score | -1.4 |
Enzon Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Enzon Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Enzon Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Enzon Pharmaceuticals competition to find correlations between indicators driving Enzon Pharmaceuticals's intrinsic value. More Info.Enzon Pharmaceuticals is rated # 3 in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Enzon Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Enzon Pharmaceuticals' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Enzon Pharmaceuticals Market Pulse
Quote | 0.2 |
Change(%) | 5.26 |
Change | 0.01 |
Open | 0.19 |
Low | 0.19 |
High | 0.2 |
Volume | 0 |
Exchange | OTCQX |
Enzon Pharmaceuticals January 30, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Enzon Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Enzon Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Enzon Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Enzon OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Enzon Pharmaceuticals's daily price indicators and compare them against related drivers.
Downside Deviation | 8.7 | |||
Information Ratio | 0.0112 | |||
Maximum Drawdown | 31.43 | |||
Value At Risk | (10.00) | |||
Potential Upside | 8.33 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Enzon Pharmaceuticals information on this page should be used as a complementary analysis to other Enzon Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Enzon OTC Stock
If you are still planning to invest in Enzon Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enzon Pharmaceuticals' history and understand the potential risks before investing.
Commodity Directory Find actively traded commodities issued by global exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
CEOs Directory Screen CEOs from public companies around the world | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements |